All Facilities , From 2026-05-18 - 2026-05-31
AMR INDICATOR 3 :: Drug Resistance
n = 281 Number of Isolates
All Specimens All Organisms
n = 281 Number of Isolates
All Specimens All Organisms
| Anntibiotic | Total Tested | Number Susceptibility | % Susceptibility |
|---|---|---|---|
| Voriconazole | 11 | 10 | 90.9 |
| Imipenem | 112 | 98 | 87.5 |
| Meropenem | 91 | 74 | 81.3 |
| Tigecycline | 5 | 4 | 80.0 |
| Vancomycin | 54 | 42 | 77.8 |
| Amoxicillin | 4 | 3 | 75.0 |
| Linezolid | 40 | 29 | 72.5 |
| Amikacin | 82 | 59 | 72.0 |
| Nitrofurantoin | 104 | 74 | 71.2 |
| Amoxicillin/Clavulanic acid | 6 | 4 | 66.7 |
| Chloramphenicol | 112 | 74 | 66.1 |
| Levofloxacin | 59 | 38 | 64.4 |
| Piperacillin/Tazobactam | 131 | 78 | 59.5 |
| Clindamycin | 80 | 47 | 58.8 |
| Doxycycline | 41 | 23 | 56.1 |
| ertapenem | 9 | 5 | 55.6 |
| Amphotericin B | 9 | 5 | 55.6 |
| Cefepime | 69 | 35 | 50.7 |
| Ceftolozane-tazobactam | 2 | 1 | 50.0 |
| Piperacillin | 8 | 4 | 50.0 |
| Nalidixic acid | 29 | 14 | 48.3 |
| Gentamicin | 167 | 77 | 46.1 |
| Rifampin | 9 | 4 | 44.4 |
| Aztreonam | 27 | 12 | 44.4 |
| Ceftazidime | 120 | 53 | 44.2 |
| Azithromycin | 14 | 6 | 42.9 |
| Kanamycin | 5 | 2 | 40.0 |
| Cefoxitin | 37 | 14 | 37.8 |
| Caspofungin | 8 | 3 | 37.5 |
| Micafungin | 8 | 3 | 37.5 |
| Amoxicillin/ Clavulanic acid | 55 | 20 | 36.4 |
| Ampicillin/ Sulbactam | 11 | 4 | 36.4 |
| Ciprofloxacin | 207 | 70 | 33.8 |
| Trimethoprim/Sulfamethoxazole | 134 | 44 | 32.8 |
| Cefotaxime | 77 | 25 | 32.5 |
| Trimethoprim | 16 | 5 | 31.3 |
| Ceftriaxone | 126 | 34 | 27.0 |
| Cefuroxime | 91 | 24 | 26.4 |
| Tetracycline | 89 | 22 | 24.7 |
| Erythromycin | 70 | 12 | 17.1 |
| Penicillin G | 50 | 8 | 16.0 |
| Fluconazole | 7 | 1 | 14.3 |
| Oxacillin | 15 | 2 | 13.3 |
| Ampicillin | 70 | 8 | 11.4 |
| Daptomycin | 1 | 1 | 100.0 |
| Flucytosine | 8 | 8 | 100.0 |
| Ceftazidime-avibactam | 2 | 2 | 100.0 |
| Minocycline | 1 | 1 | 100.0 |